If you are wondering whether Amgen's current share price still offers value after a strong run, this article walks through what the numbers are really saying about the stock. Over the last year Amgen ...
Zacks Investment Research on MSN
Amgen Inc. (AMGN) is a trending stock: Facts to know before betting on it
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Zacks Investment Research on MSN
Amgen (AMGN) stock falls amid market uptick: What investors need to know
Amgen (AMGN) ended the recent trading session at $330.05, demonstrating a -3.39% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.01%.
Amgen reported strong Q1 results with a 9% YoY revenue increase and a 24% rise in operating EPS, but shares dipped due to risk-on market sentiment. Despite competitive pressures and softer EPS trends, ...
Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13 ...
Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in ...
In early January 2026, DISCO Pharmaceuticals announced it had granted Amgen exclusive global rights to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results